Tacrolimus for Treating Orbital and Cranial Form of Idiopathic Inflammatory Pseudotumors.

CONCLUSIONS: Tacrolimus may be a safe and effective immunosuppressant for refractory or relapsing form of orbital or cranial IIPs. PMID: 33029975 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/33029975?dopt=Abstract

Source: Journal of Clinical Neurology - October 10, 2020 Category: Neurology Tags: J Clin Neurol Source Type: research

More News: Brain | Corticosteroid Therapy | Neurology | Prograf | Tacrolimus